Literature DB >> 3259156

Induction in a murine tumor of immunogenic tumor variants by transfection with a foreign gene.

E R Fearon1, T Itaya, B Hunt, B Vogelstein, P Frost.   

Abstract

Transfection of the undifferentiated murine colon carcinoma line CT-26 with the gene coding for the hemagglutination antigen (HA) of influenza virus resulted in the generation of highly immunogenic tumor cells. CT-26 cells transfected with HA not only failed to grow in syngeneic mice but also protected normal animals against a challenge with otherwise lethal doses of parental nontransfected cells. The immunogenicity of HA-transfected cells appeared to correlate with surface HA expression in that tumorigenic clones of HA-transfected CT-26 cells expressed little HA, while immunogenic clones were high expressers of HA. Irradiation of immunogenic HA clones did not abrogate their immunogenicity. These observations demonstrate that immune recognition of a poorly immunogenic tumor can be produced by immunization with tumor cells expressing a defined, foreign cell surface antigen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259156

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

Review 1.  Rationale for immunotherapy of renal cell carcinoma.

Authors:  R Heicappell; R Ackermann
Journal:  Urol Res       Date:  1990

2.  Cytotoxic activity toward mouse melanoma following immunization of mice with transfected cells expressing a human melanoma-associated antigen.

Authors:  J Nowak; E P Cohen; L H Graf
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 3.  Prospects for the therapeutic use of anticancer vaccines.

Authors:  R S Chamberlain
Journal:  Drugs       Date:  1999-03       Impact factor: 9.546

4.  HLA antigens are candidate markers for prediction of lymph node metastasis in gastric cancer.

Authors:  K Ogoshi; T Tajima; T Mitomi; K Tsuji
Journal:  Clin Exp Metastasis       Date:  1996-05       Impact factor: 5.150

5.  Retention of immunogenicity after X-irradiation of mouse colon tumor cells expressing the transfected influenza virus hemagglutinin gene.

Authors:  T Itaya; B Hunt; P Frost
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

6.  Immunogenicity of a non-class I MHC expressing murine tumor transfected with the influenza virus hemagglutinin or murine interleukin-2 genes.

Authors:  T Itaya; E Fearon; T Fiesinger; B Hunt; B Vogelstein; P Frost
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

7.  Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine.

Authors:  Dan Laheru; Barbara Biedrzycki; Elizabeth M Jaffee
Journal:  Methods Mol Biol       Date:  2013

8.  Immunity to melanoma in mice immunized with transfected allogeneic mouse fibroblasts expressing melanoma-associated antigens.

Authors:  Y S Kim; R Slomski; E P Cohen
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

9.  Mutagen-induced Imm+ variants: the need for viable and cloned Imm+ variants for effective protection against a primary murine tumor and its metastases.

Authors:  A Sella; B Hunt; P Frost
Journal:  Clin Exp Metastasis       Date:  1989 Jan-Feb       Impact factor: 5.150

10.  Localized expression of GITR-L in the tumor microenvironment promotes CD8+ T cell dependent anti-tumor immunity.

Authors:  John S Cho; Jeffrey V Hsu; Sherie L Morrison
Journal:  Cancer Immunol Immunother       Date:  2008-11-19       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.